Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pancreatic Polypeptide for Insulin Requirements in Type 1 Diabetes
NCT00791076Phase 2Terminated
- Sponsor
- Johns Hopkins University
- Start
- Oct 2007
- Primary completion
- Jun 2010
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Pancreatic polypeptide in type 1 diabetes mellitus (T1D), diabetes mellitus (DM), sponsored by Johns Hopkins University. Started Oct 2007; status: terminated.
02
Drugs
Pancreatic polypeptide
03
Conditions
type 1 diabetes mellitus (T1D)diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT00791076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00791076.